fda glp-1 compounding enforcement november 2025 Out of Shortage, Into Controversy: The Fight Over New project announcement: HHS‑OIG is

GLP-1 drugs like Ozempic and Mounjaro have shaken up pharma, crossing firmly over into the mainstream while netting fortunate suppliers billions of dollars in the process

Eli Lilly reported another success in a study pitting its once-daily oral GLP-1 therapy Orforglipron against a competing type 2 DM therapy, this time AstraZeneca's SGLT2I Farxiga (Dapagliflozin)

Behavioural testing was carried out to ascertain the effect of liraglutide on disease progression

Here's the truth about the skinny shot:

It has been clinically studied to help support GLP-1 levels and may support positive gut flora

I dreaded eating and not eating alike. Plus-I had to eat bland starchy food to not be sick so I put the weight back on